Study Summary
This trial is looking at the effects of Narrow band UVB (NB-UVB) treatment on protein expression and histological changes in skin from participants with Vitiligo.
Eligible Conditions
- Vitiligo
- Skin Conditions
Treatment Effectiveness
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 2 years
2 years
Molecular changes from NB-UVB therapy
Trial Safety
Trial Design
1 Treatment Group
Phototherapy (NB-UVB)
1 of 1
Experimental Treatment
20 Total Participants · 1 Treatment Group
Primary Treatment: Phototherapy (NB-UVB) via the 3 Series PC & SP phototherapy cabinet · No Placebo Group · N/A
Phototherapy (NB-UVB)
Device
Experimental Group · 1 Intervention: Phototherapy (NB-UVB) via the 3 Series PC & SP phototherapy cabinet · Intervention Types: DeviceTrial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 2 years
Who is running the clinical trial?
Johns Hopkins UniversityLead Sponsor
2,073 Previous Clinical Trials
31,017,205 Total Patients Enrolled
1 Trials studying Vitiligo
2 Patients Enrolled for Vitiligo
Noori Kim, M.DPrincipal InvestigatorJohns Hopkins University
Eligibility Criteria
Age 18 - 100 · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:You are able to understand the consent procedure.
Who else is applying?
What state do they live in?
| Tennessee | 50.0% |
| District of Columbia | 50.0% |
How old are they?
| 18 - 65 | 100.0% |
What site did they apply to?
| Johns Hopkins Outpatient Center | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |
How many prior treatments have patients received?
| 1 | 100.0% |
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments